BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22526518)

  • 21. The significant increase and dynamic changes of the myeloid-derived suppressor cells percentage with chemotherapy in advanced NSCLC patients.
    Wang S; Fu Y; Ma K; Liu C; Jiao X; Du W; Zhang H; Wu X
    Clin Transl Oncol; 2014 Jul; 16(7):616-22. PubMed ID: 24193866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients.
    Márquez-Coello M; Montes de Oca Arjona M; Martín-Aspas A; Guerrero Sánchez F; Fernández-Gutiérrez Del Álamo C; Girón-González JA
    Sci Rep; 2019 Aug; 9(1):11654. PubMed ID: 31406185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.
    Rudolph BM; Loquai C; Gerwe A; Bacher N; Steinbrink K; Grabbe S; Tuettenberg A
    Exp Dermatol; 2014 Mar; 23(3):202-4. PubMed ID: 24495013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer.
    Ohki S; Shibata M; Gonda K; Machida T; Shimura T; Nakamura I; Ohtake T; Koyama Y; Suzuki S; Ohto H; Takenoshita S
    Oncol Rep; 2012 Aug; 28(2):453-8. PubMed ID: 22614133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid-Derived Suppressor Cells Associated With Disease Progression in Primary HIV Infection: PD-L1 Blockade Attenuates Inhibition.
    Zhang ZN; Yi N; Zhang TW; Zhang LL; Wu X; Liu M; Fu YJ; He SJ; Jiang YJ; Ding HB; Chu ZX; Shang H
    J Acquir Immune Defic Syndr; 2017 Oct; 76(2):200-208. PubMed ID: 28570288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3ζ expression through ELF-1 inhibition.
    Tumino N; Turchi F; Meschi S; Lalle E; Bordoni V; Casetti R; Agrati C; Cimini E; Montesano C; Colizzi V; Martini F; Sacchi A
    AIDS; 2015 Nov; 29(18):2397-407. PubMed ID: 26355672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid Derived Suppressor Cells Expansion Persists After Early ART and May Affect CD4 T Cell Recovery.
    Agrati C; Tumino N; Bordoni V; Pinnetti C; Sabatini A; Amendola A; Abbate I; Lorenzini P; Mondi A; Casetti R; Cimini E; Grassi G; Antinori A; Sacchi A
    Front Immunol; 2019; 10():1886. PubMed ID: 31440256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased activity of extrinsic and intrinsic apoptosis pathways in different mononuclear cell types in HIV type 1-infected patients regardless of whether they are depleted in disease.
    Chen J; Benlahrech A; Kelleher P; Patterson S
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):709-17. PubMed ID: 23259400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Levels of myeloid-derived suppressor cells in peripheral blood of infants with recurrent wheezing].
    Wang XF; Han Y; Zhang YL; Song L; Xu CN
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1116-8. PubMed ID: 24342211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The proportion and function of peripheral myeloid-derived suppressor cells do not correlate with systemic inflammation in chronic obstructive pulmonary disease.
    Tan DB; Fernandez S; Price P; Moodley YP
    Hum Immunol; 2014 Jan; 75(1):5-9. PubMed ID: 24090682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.
    Wang L; Zhao J; Ren JP; Wu XY; Morrison ZD; Elgazzar MA; Ning SB; Moorman JP; Yao ZQ
    AIDS; 2016 Jun; 30(10):1521-1531. PubMed ID: 26959508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals.
    Nonnenmann J; Stirner R; Roider J; Jung MC; Schrödl K; Bogner JR; Draenert R
    J Virol; 2014 Jul; 88(13):7678-82. PubMed ID: 24741087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Petersen-Baltussen HM; ter Laan M; Wesseling P; Adema GJ
    J Neuropathol Exp Neurol; 2015 May; 74(5):390-400. PubMed ID: 25853692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis.
    Fernandez IE; Greiffo FR; Frankenberger M; Bandres J; Heinzelmann K; Neurohr C; Hatz R; Hartl D; Behr J; Eickelberg O
    Eur Respir J; 2016 Oct; 48(4):1171-1183. PubMed ID: 27587556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy.
    Chen HM; Ma G; Gildener-Leapman N; Eisenstein S; Coakley BA; Ozao J; Mandeli J; Divino C; Schwartz M; Sung M; Ferris R; Kao J; Wang LH; Pan PY; Ko EC; Chen SH
    Clin Cancer Res; 2015 Sep; 21(18):4073-4085. PubMed ID: 25922428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals.
    Qin A; Cai W; Pan T; Wu K; Yang Q; Wang N; Liu Y; Yan D; Hu F; Guo P; Chen X; Chen L; Zhang H; Tang X; Zhou J
    J Virol; 2013 Feb; 87(3):1477-90. PubMed ID: 23152536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocytic Myeloid-Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level.
    Tumino N; Bilotta MT; Pinnetti C; Ammassari A; Antinori A; Turchi F; Agrati C; Casetti R; Bordoni V; Cimini E; Abbate I; Capobianchi MR; Martini F; Sacchi A
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):575-582. PubMed ID: 28060224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.
    Idorn M; Køllgaard T; Kongsted P; Sengeløv L; Thor Straten P
    Cancer Immunol Immunother; 2014 Nov; 63(11):1177-87. PubMed ID: 25085000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid-derived suppressor cells in human peripheral blood: Optimized quantification in healthy donors and patients with metastatic renal cell carcinoma.
    Flörcken A; Takvorian A; Singh A; Gerhardt A; Ostendorf BN; Dörken B; Pezzutto A; Westermann J
    Immunol Lett; 2015 Dec; 168(2):260-7. PubMed ID: 26462434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute HIV-1 infection is associated with increased plasma levels of heme oxygenase-1 and presence of heme oxygenase-1-specific regulatory T cells.
    Angin M; Fathi A; King M; Ledoux MB; Piechocka-Trocha A; Altfeld M; Addo MM
    AIDS; 2017 Mar; 31(5):635-641. PubMed ID: 28060008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.